Peptide dose-response curves were done to estimate the avidity of these HTL for peptide TARP1-14 (A) and TARP14-27 (B-E) using autologous PBMCs and dendritic cells (DC) as APC. Points, triplicate determinations; bars, SD. Points without bars had SD < 10% th... Peptide dose-response curves were done to estimate the avidity of these HTL for peptide TARP1-14 (A) and TARP14-27 (B-E) using autologous PBMCs and dendritic cells (DC) as APC. Points, triplicate determinations; bars, SD. Points without bars had SD < 10% the value of the mean. Representative of at least two to three experiments that were done with the same samples. Hiroya Kobayashi et al. Clin Cancer Res 2005;11:3869-3878 ©2005 by American Association for Cancer Research